Ifetroban Shows Promise in Slowing Cardiac Decline in Duchenne Muscular Dystrophy

Findings from the phase 2 FIGHT DMD trial suggest an investigational oral thromboxane prostanoid receptor antagonist may preserve heart function in patients with DMD-associated cardiomyopathy.:

Source: Neurology Read More